Compare Nuwellis Inc (NUWE) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Vanguard Short Term Corporate Bond ETF — how do they compare? Nuwellis Inc trades at $0.8 (market cap $2.50M), while Vanguard Short Term Corporate Bond ETF trades at $78.09. Which is the better fit depends on your goals.
| NUWE | VCSH | |
|---|---|---|
Market Cap | $2.50M | — |
Sector | Technology | Fixed Income |
52-Week High | $164.50 | $80.20 |
52-Week Low | $0.73 | $78.08 |
Enterprise Value | -$1.21M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
VCSH, the Vanguard Short-Term Corporate Bond ETF, trades at $78.14 with minimal daily movement (-0.05%). The technical picture is bearish with moving averages signaling caution, though oversold RSI readings suggest potential near-term support. The ETF maintains a competitive 4.5% dividend yield with a short 2.7-year duration, positioning it defensively against rising rates while offering higher income than treasury alternatives.
While VCSH provides quality short-term corporate bond exposure with minimal interest rate risk, current tight credit spreads limit upside potential. The ETF faces competition from broader bond funds and carries corporate credit risk. Recent analyst downgrades to 'Hold' reflect concerns about entry timing, though institutional investors continue active positioning in the fund.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →
